Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1232

1.

Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer.

Suzuki K, Terakawa T, Shigemura K, Furukawa J, Harada K, Hinata N, Nakano Y, Fujisawa M.

Mol Clin Oncol. 2019 Nov;11(5):523-530. doi: 10.3892/mco.2019.1915. Epub 2019 Aug 27.

2.

Comment for "nomogram establishment for surgery-related complications in partial nephrectomy".

Shigemura K, Sung SY, Chen KC, Fujisawa M.

Ann Transl Med. 2019 Jul;7(Suppl 3):S120. doi: 10.21037/atm.2019.05.50. No abstract available.

3.

Nivolumab-induced Adrenal Insufficiency in Patients With Renal Cell Carcinoma.

Suzuki K, Terakawa T, Furukawa J, Harada K, Hinata N, Nakano Y, Fujisawa M.

J Immunother. 2019 Sep 24. doi: 10.1097/CJI.0000000000000299. [Epub ahead of print]

PMID:
31567704
4.

Ultrafast Unbalanced Electron Distributions in Quasicrystalline 30° Twisted Bilayer Graphene.

Suzuki T, Iimori T, Ahn SJ, Zhao Y, Watanabe M, Xu J, Fujisawa M, Kanai T, Ishii N, Itatani J, Suwa K, Fukidome H, Tanaka S, Ahn JR, Okazaki K, Shin S, Komori F, Matsuda I.

ACS Nano. 2019 Oct 7. doi: 10.1021/acsnano.9b06091. [Epub ahead of print]

PMID:
31553174
5.

A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study.

Inoue T, Miura M, Yanishi M, Furukawa J, Sato F, Nitta M, Yoshimura K, Hagiuda J, Shinoda K, Kobayashi T, Miyajima A, Nakagawa K, Oya M, Ogawa O, Mimata H, Kanayama HO, Fujisawa M, Terachi T, Matsuda T, Habuchi T; LESS and RPS Research Group in Japanese Society of Endourology.

Surg Endosc. 2019 Sep 23. doi: 10.1007/s00464-019-07119-9. [Epub ahead of print]

PMID:
31549237
6.

Inhibition of Tumor Growth and Sensitization to Sunitinib by RNA Interference Targeting Programmed Death-ligand 1 in Mouse Renal Cell Carcinoma RenCa Model.

Hara T, Miyake H, Hinata N, Fujisawa M.

Anticancer Res. 2019 Sep;39(9):4737-4742. doi: 10.21873/anticanres.13656.

PMID:
31519573
7.

C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab.

Suzuki K, Terakawa T, Furukawa J, Harada K, Hinata N, Nakano Y, Fujisawa M.

Int J Clin Oncol. 2019 Sep 11. doi: 10.1007/s10147-019-01528-5. [Epub ahead of print]

PMID:
31512006
8.

Urinary tract infection pathogens and antimicrobial susceptibilities in Kobe, Japan and Taipei, Taiwan: an international analysis.

Yi-Te C, Shigemura K, Nishimoto K, Yamada N, Kitagawa K, Sung SY, Chen KC, Fujisawa M.

J Int Med Res. 2019 Sep 12:300060519867826. doi: 10.1177/0300060519867826. [Epub ahead of print] No abstract available.

PMID:
31510836
9.

Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.

Sakurai S, Kato H, Yoshida Y, Sugawara Y, Fujisawa M, Yasumoto A, Matsumoto M, Fujimura Y, Yatomi Y, Nangaku M.

J Atheroscler Thromb. 2019 Sep 4. doi: 10.5551/jat.49494. [Epub ahead of print]

10.

Current status of countermeasures for infectious diseases and resistant microbes in the field of urology.

Kitano H, Teishima J, Shigemura K, Ohge H, Fujisawa M, Matsubara A.

Int J Urol. 2019 Aug 5. doi: 10.1111/iju.14087. [Epub ahead of print] Review.

PMID:
31382322
11.

Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.

Kitagawa K, Shigemura K, Sung SY, Chen KC, Huang CC, Chiang YT, Liu MC, Huang TW, Yamamichi F, Shirakawa T, Fujisawa M.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2261-2271. doi: 10.1007/s00432-019-02987-z. Epub 2019 Jul 31.

PMID:
31367836
12.

Editorial Comment to Quality of life after external beam radiotherapy for localized prostate cancer: Comparison with other modalities.

Shigemura K, Fujisawa M.

Int J Urol. 2019 Oct;26(10):954-955. doi: 10.1111/iju.14085. Epub 2019 Jul 25. No abstract available.

PMID:
31347205
13.

IMPACT ON ABSORBED DOSE RATE IN AIR IN KANTO REGION BY FUKUSHIMA DAIICHI NUCLEAR POWER PLANT ACCIDENT.

Inoue K, Arai M, Tsuruoka H, Saito K, Fujisawa M, Nakazawa S, Veerasamy N, Fukushi M.

Radiat Prot Dosimetry. 2019 Apr 26. pii: ncz073. doi: 10.1093/rpd/ncz073. [Epub ahead of print]

PMID:
31330022
14.

Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium.

Suzuki K, Koyanagi-Aoi M, Uehara K, Hinata N, Fujisawa M, Aoi T.

Sci Rep. 2019 Jul 19;9(1):10506. doi: 10.1038/s41598-019-46848-8.

15.

Appendiceal Perforation due to Migration of a Dental Instrument.

Tsukamoto R, Miyano S, Machida M, Kitabatake T, Fujisawa M, Kojima K.

Case Rep Gastroenterol. 2018 Sep 18;12(3):551-555. doi: 10.1159/000444520. eCollection 2018 Sep-Dec.

16.

Protocol for a comparison study of 1-day (single dose) versus 2-day prophylactic antibiotic administration in Holmium Laser enucleation of the prostate (HoLEP): a randomized controlled trial.

Shigemura K, Yamamichi F, Nishimoto K, Kitagawa K, Fujisawa M.

Version 2. F1000Res. 2019 Feb 6 [revised 2019 Jan 1];8:161. doi: 10.12688/f1000research.17660.2. eCollection 2019.

17.

Editorial Comment to Potential of hyperbaric oxygen in urological diseases.

Shigemura K, Fujisawa M.

Int J Urol. 2019 Sep;26(9):867. doi: 10.1111/iju.14033. Epub 2019 May 30. No abstract available.

PMID:
31148221
18.

Importance of interim restorations in the molar region.

Miura S, Fujisawa M, Komine F, Maseki T, Ogawa T, Takebe J, Nara Y.

J Oral Sci. 2019 Jun 18;61(2):195-199. doi: 10.2334/josnusd.19-0102. Epub 2019 May 21.

19.

FEASIBILITY STUDY ON THE FUSION OF PHITS SIMULATIONS AND THE DLNN ALGORITHM FOR A NEW QUANTITATIVE METHOD OF IN-SITU MULTIPLE-CHANNEL DEPTH DISTRIBUTION SPECTROMETRY.

Sakama M, Fujimoto K, Inoue K, Fukushi M, Imajyo Y, Fukuhara T, Matsuura M, Yajima T, Endo M, Fujisawa M, Matsumoto-Kawaguchi E.

Radiat Prot Dosimetry. 2019 Apr 30. pii: ncz093. doi: 10.1093/rpd/ncz093. [Epub ahead of print]

PMID:
31038704
20.

The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer.

Matsumoto K, Ohara T, Fujisawa M, Takaki A, Takahara M, Tanaka N, Kato H, Horiguchi S, Yoshida R, Umeda Y, Fushimi S, Yagi T, Matsukawa A, Okada H.

J Gastroenterol. 2019 Apr 29. doi: 10.1007/s00535-019-01586-6. [Epub ahead of print]

PMID:
31032528
21.

Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2019 Jul;23(7):985. doi: 10.1007/s10157-019-01728-3.

22.

Application of hyaluronic acid/carboxymethyl cellulose membrane for early continence after nerve-sparing robot-assisted radical prostatectomy.

Hinata N, Bando Y, Chiba K, Furukawa J, Harada K, Ishimura T, Nakano Y, Fujisawa M.

BMC Urol. 2019 Apr 23;19(1):25. doi: 10.1186/s12894-019-0458-4.

23.
24.

One-Year Impact of Kidney Transplantation on Cardiac Abnormalities and Blood Pressure in Hemodialysis Patients.

Fujii H, Watanabe S, Kono K, Watanabe K, Goto S, Ishimura T, Fujisawa M, Nishi S.

Ther Apher Dial. 2019 Apr 2. doi: 10.1111/1744-9987.12808. [Epub ahead of print]

PMID:
30941871
25.

Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.

Ueno Y, Takeuchi M, Tamada T, Sofue K, Takahashi S, Kamishima Y, Hinata N, Harada K, Fujisawa M, Murakami T.

Eur Urol. 2019 Jul;76(1):54-56. doi: 10.1016/j.eururo.2019.03.012. Epub 2019 Mar 26.

PMID:
30922688
26.

Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):505. doi: 10.1007/s12185-019-02621-1.

PMID:
30903563
27.

Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate Cancer.

Kitagawa K, Gonoi R, Tatsumi M, Kadowaki M, Katayama T, Hashii Y, Fujisawa M, Shirakawa T.

Mol Cancer Ther. 2019 May;18(5):980-990. doi: 10.1158/1535-7163.MCT-18-1105. Epub 2019 Mar 1.

PMID:
30824610
28.

External validation of nomograms for prediction of progression-free survival and liver toxicity in patients with advanced renal cell carcinoma treated with pazopanib.

Okamura Y, Hinata N, Terakawa T, Furukawa J, Harada K, Nakano Y, Nakamura I, Inoue T, Ogawa T, Fujisawa M.

Int J Clin Oncol. 2019 Jun;24(6):698-705. doi: 10.1007/s10147-019-01401-5. Epub 2019 Feb 23.

PMID:
30798395
29.

Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study.

Shigemura K, Tanaka K, Hamasuna R, Ishikawa K, Matsumoto T, Arakawa S, Kiyota H, Yamamoto S, Fujisawa M; Japanese Research Group for Urinary Tract Infection (JRGU).

Urol Int. 2019;102(3):293-298. doi: 10.1159/000496209. Epub 2019 Feb 18.

PMID:
30783034
30.

Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):377-381. doi: 10.1007/s12185-019-02615-z. Epub 2019 Feb 18. Erratum in: Int J Hematol. 2019 Mar 21;:.

PMID:
30778767
31.

Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.

Ohkura T, Yoshimura T, Fujisawa M, Ohara T, Marutani R, Usami K, Matsukawa A.

Front Immunol. 2019 Jan 22;10:17. doi: 10.3389/fimmu.2019.00017. eCollection 2019.

32.

Effect of mirabegron on tight junction molecules in primary cultured rat Sertoli cells.

Tanaka M, Chiba K, Okada K, Fujisawa M.

Andrologia. 2019 Jun;51(5):e13241. doi: 10.1111/and.13241. Epub 2019 Jan 31.

PMID:
30706522
33.

Editorial Comment to Updates in endourological management of urolithiasis.

Shigemura K, Fujisawa M.

Int J Urol. 2019 Feb;26(2):183-184. doi: 10.1111/iju.13897. Epub 2019 Jan 18. No abstract available.

PMID:
30659670
34.

Influence of elastic modulus mismatch between dentin and post-and-core on sequential bonding failure.

Teshigawara D, Ino T, Otsuka H, Isogai T, Fujisawa M.

J Prosthodont Res. 2019 Apr;63(2):227-231. doi: 10.1016/j.jpor.2018.12.003. Epub 2019 Jan 14.

PMID:
30651211
35.

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.

Mesaki K, Yamane M, Sugimoto S, Fujisawa M, Yoshimura T, Kurosaki T, Otani S, Miyoshi S, Oto T, Matsukawa A, Toyooka S.

Surg Today. 2019 May;49(5):443-450. doi: 10.1007/s00595-018-1753-5. Epub 2019 Jan 7.

PMID:
30617600
36.

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.

Ainoda Y, Aoki K, Ishii Y, Okuda K, Furukawa H, Manabe R, Sahara T, Nakamura-Uchiyama F, Kurosu H, Ando Y, Fujisawa M, Hoshino H, Arima H, Ohnishi K.

BMC Infect Dis. 2019 Jan 7;19(1):20. doi: 10.1186/s12879-018-3649-9.

37.

Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo.

Yoneda T, Kunimura N, Kitagawa K, Fukui Y, Saito H, Narikiyo K, Ishiko M, Otsuki N, Nibu KI, Fujisawa M, Serada S, Naka T, Shirakawa T.

Cancer Gene Ther. 2019 Jan 4. doi: 10.1038/s41417-018-0075-5. [Epub ahead of print]

PMID:
30607005
38.

Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing Bacteria.

Mita Y, Shigemura K, Osawa K, Kitagawa K, Kotaki T, Shirakawa T, Miyara T, Fujisawa M.

Urol Int. 2019;102(2):205-211. doi: 10.1159/000495314. Epub 2019 Jan 2.

PMID:
30602152
39.

Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials.

Kawaguchi T, Suzuki F, Imamura M, Murashima N, Yanase M, Mine T, Fujisawa M, Sato I, Yoshiji H, Okita K, Suzuki K.

Hepatol Res. 2019 Apr;49(4):404-418. doi: 10.1111/hepr.13300. Epub 2019 Feb 1.

PMID:
30589492
40.

Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy.

Okada K, Fujisawa M.

World J Mens Health. 2019 May;37(2):166-174. doi: 10.5534/wjmh.180043. Epub 2018 Nov 27. Review.

41.

Bacteremia complicating urinary tract infection by Pseudomonas aeruginosa: Mortality risk factors.

Kitagawa K, Shigemura K, Yamamichi F, Osawa K, Uda A, Koike C, Tokimatsu I, Shirakawa T, Miyara T, Fujisawa M.

Int J Urol. 2019 Mar;26(3):358-362. doi: 10.1111/iju.13872. Epub 2018 Dec 21.

PMID:
30575137
42.

Total necrosis after sequential treatment with pazopanib followed by nivolumab in a patient with renal cell carcinoma involving the inferior vena cava.

Shiraishi Y, Terakawa T, Jimbo N, Shigemura K, Hinata N, Fujisawa M.

Int J Urol. 2019 Feb;26(2):313-314. doi: 10.1111/iju.13853. Epub 2018 Nov 14. No abstract available.

PMID:
30430647
43.

Periodontitis, periodontal inflammation, and mild cognitive impairment: A 5-year cohort study.

Iwasaki M, Kimura Y, Ogawa H, Yamaga T, Ansai T, Wada T, Sakamoto R, Ishimoto Y, Fujisawa M, Okumiya K, Miyazaki H, Matsubayashi K.

J Periodontal Res. 2019 Jun;54(3):233-240. doi: 10.1111/jre.12623. Epub 2018 Oct 21.

PMID:
30345659
44.

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan.

Harada K, Nozawa M, Uemura M, Tatsugami K, Osawa T, Yamana K, Kimura G, Fujisawa M, Nonomura N, Eto M, Shinohara N, Tomita Y, Kondo Y, Ochi K, Anazawa Y, Uemura H.

Int J Urol. 2019 Feb;26(2):202-210. doi: 10.1111/iju.13830. Epub 2018 Oct 21.

PMID:
30345560
45.

Photo-induced semimetallic states realised in electron-hole coupled insulators.

Okazaki K, Ogawa Y, Suzuki T, Yamamoto T, Someya T, Michimae S, Watanabe M, Lu Y, Nohara M, Takagi H, Katayama N, Sawa H, Fujisawa M, Kanai T, Ishii N, Itatani J, Mizokawa T, Shin S.

Nat Commun. 2018 Oct 17;9(1):4322. doi: 10.1038/s41467-018-06801-1.

46.

Molecular characteristics of carbapenem-resistant Pseudomonas aeruginosa isolated from urine in Hyogo, Japan.

Osawa K, Shigemura K, Kitagawa K, Fukuda T, Takasaka A, Wakabayashi S, Sato K, Yamamichi F, Shirakawa T, Fujisawa M.

Int J Urol. 2019 Jan;26(1):127-133. doi: 10.1111/iju.13818. Epub 2018 Oct 11.

PMID:
30308701
47.

Predictive factors of improvement for voiding symptoms after holmium laser enucleation of the prostate.

Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M.

Int J Urol. 2019 Jan;26(1):136-137. doi: 10.1111/iju.13825. Epub 2018 Oct 11. No abstract available.

PMID:
30308697
48.

Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.

Fujisawa M, Moh-Moh-Aung A, Zeng Z, Yoshimura T, Wani Y, Matsukawa A.

PLoS One. 2018 Oct 10;13(10):e0205494. doi: 10.1371/journal.pone.0205494. eCollection 2018.

49.

Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.

Suzuki K, Sakamoto M, Terakawa T, Furukawa J, Harada K, Hinata N, Nakano Y, Fujisawa M.

Anticancer Res. 2018 Oct;38(10):5929-5935. doi: 10.21873/anticanres.12938.

PMID:
30275221
50.

Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.

Kuntaman K, Shigemura K, Osawa K, Kitagawa K, Sato K, Yamada N, Nishimoto K, Yamamichi F, Rahardjo D, Hadi U, Mertaniasih NM, Kinoshita S, Fujisawa M, Shirakawa T.

Int J Urol. 2018 Nov;25(11):966-972. doi: 10.1111/iju.13787. Epub 2018 Sep 25.

PMID:
30253445

Supplemental Content

Loading ...
Support Center